Literature DB >> 16159986

Cardiac resynchronisation therapy in chronic atrial fibrillation: impact on left atrial size and reversal to sinus rhythm.

P Kiès1, C Leclercq, G B Bleeker, C Crocq, S G Molhoek, C Poulain, L van Erven, M Bootsma, K Zeppenfeld, E E van der Wall, J-C Daubert, M J Schalij, J J Bax.   

Abstract

OBJECTIVE: To evaluate the impact of long term cardiac resynchronisation therapy (CRT) on left atrial and left ventricular (LV) reverse remodelling and reversal to sinus rhythm (SR) in patients with heart failure with atrial fibrillation (AF). PATIENTS: 74 consecutive patients (age 68 (8) years; 67 men) with advanced heart failure and AF (20 persistent and 54 permanent) were implanted with a CRT device. MAIN OUTCOME MEASURES: Patients were evaluated clinically (New York Heart Association (NYHA) class, quality of life, six minute walk test) and echocardiographically (LV ejection fraction, LV diameters, and left atrial diameters) before and after six months of CRT. Additionally, restoration of SR was evaluated after six months of CRT.
RESULTS: NYHA class, quality of life score, six minute walk test, and LV ejection fraction had improved significantly after six months of CRT. In addition, left atrial and LV end diastolic and end systolic diameters had decreased from 59 (9) to 55 (9) mm, from 72 (10) to 67 (10) mm, and from 61 (11) to 56 (11) mm, respectively (all p < 0.01). During implantation 18 of 20 (90%) patients with persistent AF were cardioverted to SR. At follow up 13 of 18 (72%) patients had returned to AF and none had spontaneously reverted to SR; thus, only 5 of 74 (7%) were in SR.
CONCLUSION: Six months of CRT resulted in significant clinical benefit with significant left atrial and LV reverse remodelling. Despite these beneficial effects, 93% of patients had not reverted to SR.

Entities:  

Mesh:

Year:  2005        PMID: 16159986      PMCID: PMC1860874          DOI: 10.1136/hrt.2005.064816

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  30 in total

1.  Spontaneous conversion of atrial fibrillation in the setting of biventricular pacing.

Authors:  Julia H Indik
Journal:  Cardiol Rev       Date:  2004 Jan-Feb       Impact factor: 2.644

2.  Spontaneous conversion of permanent atrial fibrillation into stable sinus rhythm after 17 months of biventricular pacing.

Authors:  Klaus Malinowski
Journal:  Pacing Clin Electrophysiol       Date:  2003-07       Impact factor: 1.976

3.  Effect of cardiac resynchronization therapy on left atrial reverse remodeling and spontaneous echo contrast.

Authors:  Ahmet Vural; Aysen Ağaçdiken; Dilek Ural; Tayfun Sahin; Guliz Kozdağ; Goksel Kahraman; Ertan Ural; Haluk Akbaş; Kaya Süzer; Baki Komsuoğlu
Journal:  Tohoku J Exp Med       Date:  2004-02       Impact factor: 1.848

4.  Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements.

Authors:  D J Sahn; A DeMaria; J Kisslo; A Weyman
Journal:  Circulation       Date:  1978-12       Impact factor: 29.690

Review 5.  Catheter ablation or modulation of the AV node.

Authors:  Etienne Aliot; Christian De Chillou; Nicolas Sadoul
Journal:  Card Electrophysiol Rev       Date:  2002-12

6.  Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation.

Authors:  Merritt H Raitt; Walter Kusumoto; George Giraud; John H McAnulty
Journal:  J Cardiovasc Electrophysiol       Date:  2004-05

7.  Dissociation between ionic remodeling and ability to sustain atrial fibrillation during recovery from experimental congestive heart failure.

Authors:  Tae-Joon Cha; Joachim R Ehrlich; Liming Zhang; Yan-Fen Shi; Jean-Claude Tardif; Tack Ki Leung; Stanley Nattel
Journal:  Circulation       Date:  2004-01-12       Impact factor: 29.690

8.  Left ventricular remodelling and haemodynamic effects of multisite biventricular pacing in patients with left ventricular systolic dysfunction and activation disturbances in sinus rhythm: sub-study of the MUSTIC (Multisite Stimulationin Cardiomyopathies) trial.

Authors:  A Duncan; D Wait; D Gibson; J-C Daubert
Journal:  Eur Heart J       Date:  2003-03       Impact factor: 29.983

9.  Left ventricular mechanics during right ventricular apical or left ventricular-based pacing in patients with chronic atrial fibrillation after atrioventricular junction ablation.

Authors:  Emmanuel N Simantirakis; Konstantinos E Vardakis; George E Kochiadakis; Emmanuel G Manios; Nikolaos E Igoumenidis; Michele Brignole; Panos E Vardas
Journal:  J Am Coll Cardiol       Date:  2004-03-17       Impact factor: 24.094

10.  Electrical remodeling of the atria in congestive heart failure: electrophysiological and electroanatomic mapping in humans.

Authors:  Prashanthan Sanders; Joseph B Morton; Neil C Davidson; Steven J Spence; Jitendra K Vohra; Paul B Sparks; Jonathan M Kalman
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

View more
  12 in total

1.  Nonpharmacological Treatment of Atrial Fibrillation: What Is the Role of Device Therapy?

Authors:  Lucie Riedlbauchová; Václav Durdil; Jakub Honěk; Josef Veselka
Journal:  Int J Angiol       Date:  2020-04-28

2.  Relation of gender and interatrial dyssynchrony on tissue Doppler imaging to the prediction of the progression to chronic atrial fibrillation in patients with nonvalvular paroxysmal atrial fibrillation.

Authors:  Koichi Sakabe; Nobuo Fukuda; Yamato Fukuda; Satofumi Morishita; Hisanori Shinohara; Yoshiyuki Tamura
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

3.  Advanced Interatrial Block Predicts New Onset Atrial Fibrillation in Patients with Severe Heart Failure and Cardiac Resynchronization Therapy.

Authors:  Fariha Sadiq Ali; Andres Enriquez; Diego Conde; Damian Redfearn; Kevin Michael; Christopher Simpson; Hoshiar Abdollah; Antoni Bayés de Luna; Wilma Hopman; Adrian Baranchuk
Journal:  Ann Noninvasive Electrocardiol       Date:  2015-02-02       Impact factor: 1.468

4.  Interstitial lung abnormalities and reduced exercise capacity.

Authors:  Tracy J Doyle; George R Washko; Isis E Fernandez; Mizuki Nishino; Yuka Okajima; Tsuneo Yamashiro; Miguel J Divo; Bartolome R Celli; Frank C Sciurba; Edwin K Silverman; Hiroto Hatabu; Ivan O Rosas; Gary M Hunninghake
Journal:  Am J Respir Crit Care Med       Date:  2012-01-20       Impact factor: 21.405

Review 5.  Role of Atrio-Ventricular Junction Ablation in Symptomatic Atrial Fibrillation for Optimization of Cardiac Resynchronization Therapy.

Authors:  Paul J Garabelli; Stavros Stavrakis
Journal:  J Atr Fibrillation       Date:  2013-04-06

Review 6.  Atrial Fibrillation Complicating Congestive Heart Failure: Electrophysiological Aspects And Its Deleterious Effect On Cardiac Resynchronization Therapy.

Authors:  Osmar Antonio Centurión
Journal:  J Atr Fibrillation       Date:  2009-06-01

Review 7.  Is cardiac resynchronization therapy an antiarrhythmic therapy for atrial fibrillation? A systematic review and meta-analysis.

Authors:  Paul L Hess; Kevin P Jackson; Vic Hasselblad; Sana M Al-Khatib
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

8.  Feasibility and efficacy of electrical cardioversion after cardiac resynchronization implantation in patients with permanent atrial fibrillation.

Authors:  Pietro Turco; Antonio D'Onofrio; Giuseppe Stabile; Francesco Solimene; Vincenzo La Rocca; Filippo Vecchione; Assunta Iuliano; Natale Marrazzo; Stefano De Vivo; Ciro Cavallaro; Valter Bianchi; Alessia Agresta; Carmine Ciardiello; Antonio De Simone
Journal:  J Interv Card Electrophysiol       Date:  2012-08-14       Impact factor: 1.900

Review 9.  Disease-specific health-related quality of life questionnaires for heart failure: a systematic review with meta-analyses.

Authors:  Olatz Garin; Montse Ferrer; Angels Pont; Montserrat Rué; Anna Kotzeva; Ingela Wiklund; Eric Van Ganse; Jordi Alonso
Journal:  Qual Life Res       Date:  2008-12-04       Impact factor: 4.147

10.  Effect of cardiac resynchronization therapy on conversion of persistent atrial fibrillation to sinus rhythm.

Authors:  Melanie Hauck; Alexander Bauer; Frederik Voss; Hugo A Katus; Ruediger Becker
Journal:  Clin Res Cardiol       Date:  2008-11-25       Impact factor: 5.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.